Hertraz


Drug Name:

Trastuzumab 150mg, 440mg Injection

Category:

International Brand: Herceptin

Details


Purpose

Trastuzumab 150mg, 440mg injection is used for the treatment of breast cancer, multiple myeloma, and ovarian cancer.  The injection is used as an adjunct treatment for cancer. The medicine is also helpful in the treatment with medicines like doxorubicin, cyclophosphamide, paclitaxel, and docetaxel. The medication comes under the international brand of Herceptin and an Indian brand name of hertraz.

 

How does it work?

Trastumab 150mg,440mg injection comes under the category of alkylating agents. This medication works by stopping the growth of cancer cells in the user body.  this medication is useful in controlling the multiplication of cancer cells.

 

Measures and precautions

  1. Trastuzumab 150mg, 440mg injection is prescribed for the treatment of certain types of cancer like ovarian, breast cancer, and multiple myeloma.
  2. Herceptin injection is indicated for the use of adjuvant treatment.
  3. Hertraz injection is taken as instructed by the doctor. The medicine is taken once a day as prescribed by the concerned doctor.
  4. It is highly recommended to intake the trastuzumab 150mg, 440mg injection with other adjuncts to reduce the chances of side-effects.
  5. The doses of hertraz injection are based on the patient’s medical conditions and response towards the medicine.
  6. Do carefully read the instructions before consuming the injection. It is highly advised to do so.
  7. Avoid increasing and decreasing the doses by yourself without a doctor’s consultation. Doing so will increase your side-effects and harm the body.
  8. The hertraz injection is taken for atleast several months to observe the changes in the body.
  9. Do not get vaccinated while on use of this injection. Do avoid meeting with people who have taken the flu vaccine.
  10. Tell your doctor about any kind of allergies you have before taking the medication.
  11. In case of having kidney problems, do state all abnormalities before intaking the injection.
  12. If an overdose situation happens, the doctor should be contacted immediately.

 

Side-effects

  • Vomiting
  • Nausea
  • Lip sores
  • Mouth sores
  • Diarrhea
  • Loss of appetite
  • Temporary hair loss
  • Shortness of breath
  • Symptoms of liver damages
  • Stomach pains
  • Dark urine
  • Yellowing of skin

 

Interactions

Drug interactions are observed with this injection is of prescription type or non-prescription type. Always take the advice of the doctor for starting and stopping any kind of other drugs with this injection. This will ensure minimum side-effects in the body. nalidixic acid can be taken with this injection.

Frequently Asked Questions

1. What is Hertraz?
Hertraz is an anti-cancer medicine containing trastuzumab, a recombinant humanized monoclonal antibody that targets the HER2 (human epidermal growth factor receptor 2) protein. It is used as a targeted therapy for certain HER2-positive cancers.

2. What is Hertraz used for?
Hertraz (trastuzumab) is used in the treatment of certain HER2-positive breast cancers and HER2-positive gastric or gastroesophageal junction cancers, depending on the approved indication and treatment protocol in the relevant market. HER2 status is generally established through appropriate diagnostic testing before treatment.

3. How does Hertraz work?
Trastuzumab binds to the HER2 receptor on cancer cells and interferes with HER2-mediated signaling involved in cell growth and survival. This targeted mechanism can help inhibit the growth of HER2-positive cancer cells.

4. What strengths of Hertraz are available?
Hertraz is available in presentations including 150 mg and 440 mg powder for concentrate for solution for intravenous infusion. Product availability, packaging and regulatory requirements may vary according to the destination country.

5. How is Hertraz administered?
Hertraz is administered through intravenous infusion by a qualified healthcare professional. The dosage and treatment schedule depend on the cancer type, treatment regimen, body weight and clinical condition. It should not be self-administered.